Neurocognitive disorders in oncology
How to recognize, prevent and treat them
Neurocognitive disorders in oncology
How to recognize, prevent and treat them
Neurocognitive disorders affect up to 75% of patients undergoing oncological therapies such as radiotherapy, chemotherapy and immunotherapy.
These include learning disabilities, cognitive deficits, disorders related to executive functions and many other disorders that can significantly affect the lives of patients both in terms of professional activity and recreational activities. The aim of the conference is to review the possible treatments and prevention methods.
These include learning disabilities, cognitive deficits, disorders related to executive functions and many other disorders that can significantly affect the lives of patients both in terms of professional activity and recreational activities. The aim of the conference is to review the possible treatments and prevention methods.
Neurocognitive disorders affect up to 75% of patients undergoing oncological therapies such as radiotherapy, chemotherapy and immunotherapy.
These include learning disabilities, cognitive deficits, disorders related to executive functions and many other disorders that can significantly affect the lives of patients both in terms of professional activity and recreational activities. The aim of the conference is to review the possible treatments and prevention methods.
These include learning disabilities, cognitive deficits, disorders related to executive functions and many other disorders that can significantly affect the lives of patients both in terms of professional activity and recreational activities. The aim of the conference is to review the possible treatments and prevention methods.
Cognitive impairment in the presence of brain metastases and radiotherapy: mechanisms of damage prevention
it
Dr. Fabio Busato
Cognitive disorders in oncology: causes, pathophysiology and prevalence
it
Dr. Alessandro Salvalaggio
Neuropsychological rehabilitation in cancer patients
it
Dr. Pamela Iannizzi
Cognitive impairment from chemotherapy in patients with primary brain tumors: a drop in the ocean
it
Dr. Mario Caccese
Cognitive impairment in melanoma patients
it
Dr. Vanna Chiarioni Sileni
Cognitive deficit: assessment and psychological and family consequences
it
Dr. Eleonora Bergo
Role of MRI in personalizing therapies and risk modeling
it
Dr. Marco Fusella
Psychiatric complications in neuro-oncology, characteristics and treatment
it
Dr. Matteo Poletto